Skip to Content
Duotrope logo Duotrope®

Rogue Agent Journal

Recent cover image or website screenshot for Rogue Agent Journal © Rogue Agent Journal

Go to publication's website

Report:
Submission/Response
Correction/Update
New Cover Art

For the Editor(s):
Request Interview
Duosuma Submission Manager
Link to Duotrope

A project of Sundress Publications (see other related projects).

About

167 members set this magazine as a Favorite.

A body is the most genuine thing we have. A body can burst forth into a magic-realist galaxy. A body can be a source of pleasure. Pain can be a muse. Where does psychic pain end and visceral pain begin?
When I say sensuality, does that connote pain or pleasure? Writing the body is writing what we know because we inhabit it. Or you might write your lover's body so you can keep it with you.
If I say I am holding your hand right now can you feel it? Do you feel it with your brain or your skin?
Our bodies can make us feel powerful or defenseless. Taking a risk to write about the body can make you feel powerful.
When I wake and put my feet on the floor I feel defenseless. I would like to reclaim the word sensitive to mean risk-taker.
We are gods of our own bodies. We are servants to our own bodies. Our bodies are signifiers. Our bodies are false signifiers. Our bodies are liars. Our bodies are truthtellers.
If our bodies are oppressed by an outside force, we are "written over." Rogue Agent wants to dismantle oppression. Rogue Agent wants to empower the body’s truth. Share your stories about the poem that is the body.

Important: Submit no more often than twice a year.
Want more insight into the editors' preferences? Read our interview with the editor(s).

Country of Publication & Year Established

United States Established in 2015

Publication Medium & Frequency

Electronic Publication Electronic PublicationPublished 12 x per year.

Poetry Open
Audience:

Open to a broad Audience.

Genres:
GenreSubgenres
General GeneralOpen to all/most Subgenres.
Lengths:
Poem PoemNo line limits known; Up to 5 pieces.
Poetry Forms:

Open to all/most Forms, including: Experimental poetry, Free verse, Narrative poetry.

Styles:

Open to all/most Styles, including: Dark, Experimental, Literary.

Topics:

Open to all/most Topics.

Payment:

No monetary payment No monetary payment.

Submissions:

Method: Email.
Reprints: Reprints are NOT allowed.
Simultaneous submissions: Simultaneous submissions are allowed.
Media: Text.

Visual Art Open
Audience:

Open to a broad Audience.

Lengths:
Artwork Artwork3 - 5 pieces.
Art Media:

Open to all/most Art Media, including: Illustration, Collage, Painting, Photography.

Art Styles:

Open to all/most Art Styles.

Topics:

Open to all/most Topics.

Payment:

No monetary payment No monetary payment.

Submissions:

Method: Email.
Reprints: Reprints are NOT allowed.
Simultaneous submissions: Simultaneous submissions are allowed.
Media: Image.

Always check guidelines for details and restrictions. If you aren't familiar with these terms, see our glossary.

Rogue Agent Journal Submission Statistics — Free Preview!

The statistics in this section are compiled from submission reports sent to us through our submission tracker. They are not provided by the publication's editors/staff or by Duotrope's admins. Information in this section is updated a few times per day. Learn more about the statistics.
This project ranks among the 25 Most Approachable Poetry Publishers in our database.
AccuracyWe have received 46 reports from 45 different members within the past 12 months, not including pending responses (see below). The more responses reported, the more accurate the information.
Days Reported0 min | 79.1 mean avg | 94.0 median | 219 max days (153.0 std dev)
Responses95.65 %
Acceptances34.78 % of submissions accepted (70.6 avg. days per acceptance) | 35.56 % of submitters accepted Rejections are often underreported, which skews the statistics in favor of acceptances. Most publishers have a lower acceptance rate than indicated here.
Rejections60.87 % (80.5 avg. days per rejection) | 39.3 % personal, 25.0 % form, 35.7 % unspecified
Non-Responses4.35 %
Lost/Returned-
Never Responded-
Withdrawals4.35 % (25.5 avg. days per withdrawal)
Pending10 responses are pending (20 min | 91.5 mean avg | 96.0 median | 171 max days waiting | 222.8 std dev) from 9 different members This only includes pending reports from users who have been active on Duotrope within the past 30 days

Other Information

The editors will try to make a decision within 90 days. (54.4 % of the responses reported to us for this listing have taken longer than 90 days.)
Do not query on the status of your submission before 90 days have passed.
Submissions are acknowledged within 40 days on average.
Most recent response reported was received on 25 Nov 2024.
Responses have been received for submissions sent as recently as 12 Aug 2024.

Work submitted here was also submitted to...

This section is available to subscribers only. Sign up and start your free trial today!

Members accepted here also had work accepted by...

This section is available to subscribers only. Become a member and start your free trial today!

Your Submissions

This section is available to subscribers only. Join today!

Dates

Last Updated: 01 Oct 2024
Last Audited: 04 Jul 2024. (We audit each active listing twice a year. Learn more at link.)
Date Added: 01 Apr 2015

Before Submitting

We cannot guarantee that the information on this page is correct. It is not unusual for publications to evolve or close without notice. We do our best to keep up, but it isn't always possible. Duotrope listings do not imply endorsement or recommendation of the project being listed. Before submitting, you should use your own judgment to determine whether the project meets your standards.

  • Always read the full guidelines provided by the publisher.
  • Try to read at least one previous publication to get a better idea of what the editor would like to see.
  • Unless the publisher's guidelines state otherwise, always use industry standard manuscript formatting.
  • Be professional, patient, and persistent.